These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2719745)

  • 41. Absorption, distribution, elimination and metabolism of 14C-heptaminol hydrochloride in rat.
    Chanoine F; Benedetti MS; Ancher JF; Dostert P
    Arzneimittelforschung; 1981; 31(9):1430-5. PubMed ID: 7197949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid reversal of angiotensin I-induced contractions in rat carotid arteries after acute and chronic treatment with the angiotensin-converting enzyme inhibitor, 3-[(5-amino-1-carboxy-1S-pentyl)amino]2,3,4,5-tetrahydro-2-oxo- 3S-1H-1-benzazepena-1-acetic acid (CGS 16617).
    Weiss GB; Sturm B; Levens NR
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1407-13. PubMed ID: 8263802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of a new antihypertensive pyrrolyl pyridazinamine (MDL-899) in the rat and the dog.
    Assandri A; Bellasio E; Bernareggi A; Cristina T; Perazzi A; Odasso G
    Arzneimittelforschung; 1985; 35(2):508-13. PubMed ID: 3855234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride.
    Kaiser G; Ackermann R; Gschwind HP; James IM; Sprengers D; McIntyre N; Defalco A; Holmes IB
    Biopharm Drug Dispos; 1990 Dec; 11(9):753-64. PubMed ID: 2271751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disposition of alpha-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)- 1H-indole-3-methanol (59-801), a hypoglycaemic agent in rats, dogs and monkeys.
    Tse FL; Orwig B; Jaffe JM
    Xenobiotica; 1987 Jun; 17(6):741-9. PubMed ID: 3630208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog.
    Uchida T; Nakamura E; Usui T; Imasaki H; Kawakami R; Watanabe T; Higuchi S
    Xenobiotica; 1994 Dec; 24(12):1223-36. PubMed ID: 7771109
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absorption, distribution and excretion of a new thienodiazepine derivative (Y-7131) in rats and mice.
    Kato Y; Nishimine H
    Arzneimittelforschung; 1978; 28(7):1170-3. PubMed ID: 39572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
    DeLong AF; Smyth RD; Polk A; Nayak RK; Martin G; Douglas GH; Reavey-Cantiwell NH
    Drug Metab Dispos; 1977; 5(2):122-31. PubMed ID: 15804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.
    DeLong AF; Martin GP; Polk A; Carter V; Herczeg T
    Arzneimittelforschung; 1978; 28(8a):1477-80. PubMed ID: 113016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The metabolic disposition of etodolac in rats, dogs, and man.
    Cayen MN; Kraml M; Ferdinandi ES; Greselin E; Dvornik D
    Drug Metab Rev; 1981; 12(2):339-62. PubMed ID: 6461537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The physiological disposition of the anti-tussive agent, 1,2,3,4a,9b-hexahydro-8,9b-dimethyl-4-[3-(4-methylpiperazin-1-yl)propionamido]dibenzofuran-3-one dihydrochloride Azipranone, in man, rat, dog and baboon.
    Daniel JW; James GW; Rowlands DA; Taylor JB
    Xenobiotica; 1978 May; 8(5):321-9. PubMed ID: 96617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacokinetics of benazepril relative to other ACE inhibitors.
    Gengo FM; Brady E
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV44-50; discussion IV51-5. PubMed ID: 1893642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man.
    Hucker HB; Stauffer SC; Balletto AJ; White SD; Zacchei AG; Arison BH
    Drug Metab Dispos; 1978; 6(6):659-72. PubMed ID: 33029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.
    Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypertensive mechanism of action of the novel angiotensin converting enzyme inhibitor benazepril. Effect on isolated vascular preparations.
    Kuroda K; Fukuda Y; Nakao K; Inukai T
    Arzneimittelforschung; 1990 Sep; 40(9):968-73. PubMed ID: 2080946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.